188 related articles for article (PubMed ID: 31490705)
1. Bone marrow osteoprogenitors are depleted whereas osteoblasts are expanded independent of the osteogenic vasculature in response to zoledronic acid.
Hughes R; Chen X; Hunter KD; Hobbs JK; Holen I; Brown NJ
FASEB J; 2019 Nov; 33(11):12768-12779. PubMed ID: 31490705
[TBL] [Abstract][Full Text] [Related]
2. Zoledronate inhibits the differentiation potential of adipose-derived stem cells into osteoblasts in repairing jaw necrosis.
Qu X; Wang Z; Wu K; Wang Y; Shan L
Mol Cell Probes; 2020 Jun; 51():101525. PubMed ID: 31982509
[TBL] [Abstract][Full Text] [Related]
3. Dose-Dependent Effects of Zoledronic Acid on Human Periodontal Ligament Stem Cells: An
Di Vito A; Chiarella E; Baudi F; Scardamaglia P; Antonelli A; Giudice D; Barni T; Fortunato L; Giudice A
Cell Transplant; 2020; 29():963689720948497. PubMed ID: 33086890
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells.
Ubellacker JM; Haider MT; DeCristo MJ; Allocca G; Brown NJ; Silver DP; Holen I; McAllister SS
Breast Cancer Res; 2017 Mar; 19(1):23. PubMed ID: 28264701
[TBL] [Abstract][Full Text] [Related]
5. Rapid Osteogenic Enhancement of Stem Cells in Human Bone Marrow Using a Glycogen-Synthease-Kinase-3-Beta Inhibitor Improves Osteogenic Efficacy In Vitro and In Vivo.
Clough BH; Zeitouni S; Krause U; Chaput CD; Cross LM; Gaharwar AK; Gregory CA
Stem Cells Transl Med; 2018 Apr; 7(4):342-353. PubMed ID: 29405665
[TBL] [Abstract][Full Text] [Related]
6. Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells.
Hosogane N; Huang Z; Rawlins BA; Liu X; Boachie-Adjei O; Boskey AL; Zhu W
Int J Biochem Cell Biol; 2010 Jul; 42(7):1132-41. PubMed ID: 20362069
[TBL] [Abstract][Full Text] [Related]
7. DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age.
Kim HN; Chang J; Shao L; Han L; Iyer S; Manolagas SC; O'Brien CA; Jilka RL; Zhou D; Almeida M
Aging Cell; 2017 Aug; 16(4):693-703. PubMed ID: 28401730
[TBL] [Abstract][Full Text] [Related]
8. Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified bone niche.
Birmingham E; Niebur GL; McHugh PE; Shaw G; Barry FP; McNamara LM
Eur Cell Mater; 2012 Jan; 23():13-27. PubMed ID: 22241610
[TBL] [Abstract][Full Text] [Related]
9. Prolonged exposure to bacterial toxins downregulated expression of toll-like receptors in mesenchymal stromal cell-derived osteoprogenitors.
Mo IF; Yip KH; Chan WK; Law HK; Lau YL; Chan GC
BMC Cell Biol; 2008 Sep; 9():52. PubMed ID: 18799018
[TBL] [Abstract][Full Text] [Related]
10. Smurf1 inhibits mesenchymal stem cell proliferation and differentiation into osteoblasts through JunB degradation.
Zhao L; Huang J; Guo R; Wang Y; Chen D; Xing L
J Bone Miner Res; 2010 Jun; 25(6):1246-56. PubMed ID: 20200942
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31.
Baglìo SR; Devescovi V; Granchi D; Baldini N
Gene; 2013 Sep; 527(1):321-31. PubMed ID: 23827457
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of osteogenic differentiation in stromal cells of giant cell tumour of bone by zoledronic acid.
Yang T; Zheng XF; Li M; Lin X; Yin QS
Asian Pac J Cancer Prev; 2013; 14(9):5379-83. PubMed ID: 24175830
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of human umbilical cord blood-derived mesenchymal stem cells or their conditioned medium prevents bone loss in ovariectomized nude mice.
An JH; Park H; Song JA; Ki KH; Yang JY; Choi HJ; Cho SW; Kim SW; Kim SY; Yoo JJ; Baek WY; Kim JE; Choi SJ; Oh W; Shin CS
Tissue Eng Part A; 2013 Mar; 19(5-6):685-96. PubMed ID: 23215868
[TBL] [Abstract][Full Text] [Related]
14. Oestrogen receptor positive breast cancer metastasis to bone: inhibition by targeting the bone microenvironment in vivo.
Holen I; Walker M; Nutter F; Fowles A; Evans CA; Eaton CL; Ottewell PD
Clin Exp Metastasis; 2016 Mar; 33(3):211-24. PubMed ID: 26585891
[TBL] [Abstract][Full Text] [Related]
15. The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent.
Tahaei SE; Couasnay G; Ma Y; Paria N; Gu J; Lemoine BF; Wang X; Rios JJ; Elefteriou F
Bone; 2018 Jan; 106():103-111. PubMed ID: 29032173
[TBL] [Abstract][Full Text] [Related]
16. Conditional loss of CaMKK2 in Osterix-positive osteoprogenitors enhances osteoblast function in a sex-divergent manner.
Mattingly BT; Kambrath AV; Ding X; Thompson WR; Sankar U
Bone; 2024 Jul; 184():117113. PubMed ID: 38703937
[TBL] [Abstract][Full Text] [Related]
17. atf4 promotes β-catenin expression and osteoblastic differentiation of bone marrow mesenchymal stem cells.
Yu S; Zhu K; Lai Y; Zhao Z; Fan J; Im HJ; Chen D; Xiao G
Int J Biol Sci; 2013; 9(3):256-66. PubMed ID: 23494915
[TBL] [Abstract][Full Text] [Related]
18. Acute Phosphate Restriction Impairs Bone Formation and Increases Marrow Adipose Tissue in Growing Mice.
Ko FC; Martins JS; Reddy P; Bragdon B; Hussein AI; Gerstenfeld LC; Demay MB
J Bone Miner Res; 2016 Dec; 31(12):2204-2214. PubMed ID: 27324177
[TBL] [Abstract][Full Text] [Related]
19. Conditioned Medium Enhances Osteogenic Differentiation of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
Zhong S; He X; Li Y; Lou X
Tissue Eng Regen Med; 2019 Apr; 16(2):141-150. PubMed ID: 30989041
[TBL] [Abstract][Full Text] [Related]
20. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity.
Lee NJ; Doyle KL; Sainsbury A; Enriquez RF; Hort YJ; Riepler SJ; Baldock PA; Herzog H
J Bone Miner Res; 2010 Aug; 25(8):1736-47. PubMed ID: 20200977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
